Provider review
Peak Wellness Review: Four Named Pharmacies and a Moved Decimal
Peak Wellness names Emerald Compounding Pharmacy as the compounder of its medication, which makes its supply chain checkable rather than merely asserted — almost nothing else in this category does that. It then prints “20-22% average body weight loss in clinical trials”, a figure that is neither an average nor from a trial of what it sells.
Names its compounder, which almost nobody does — and then borrows a branded drug's best-case trial result and calls it an average.
Worth trusting if
- You want to know which pharmacy compounds your medication and be able to check it
- You want a stated physician credential and review turnaround
- You have already discounted the 20-22% headline
Be skeptical if
- You are taking that figure as what to expect
- You want the test results the named pharmacy could supply
- You want to pay month to month at the entry price, which does not persist
Compounded only
Phase 3 trials
Named
None found
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
Opens trypeak.com. A link is not a recommendation to take anything.
Provenance
What Peak Wellness actually dispenses
Regulatory category is the axis consumers are most reliably misled about, so it comes first. Every product below is sorted by what it legally is, not by what it costs.
Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
- Compounded GLP-1 injection — Read 2026-08-10 as one ladder. Re-read 2026-08-26 by walking the signup: Peak runs a separate ladder per molecule behind a toggle, and the figures previously filed here were the semaglutide ones. Tirzepatide is $279 for the first month and $349/mo after that, or $279/mo billed every three months, or $232/mo billed every six. Semaglutide runs lower — $179 first month, $249/mo after, $199/mo on three months, $165/mo on six. The advertised "Start For Just" figure is the semaglutide first month, so it is neither this product nor a rate that persists past month one.
Evidence
Has the molecule been tested for what it is sold for?
One row per product, graded on how far the published human evidence goes for the MOLECULE inside it, for the use it is sold for — not for the molecule in general, and never a claim about this seller. Nobody trials a compounded preparation; what a trial can tell you is whether the molecule has been tested for the thing it is being advertised to do. A molecule with phase 3 evidence for one outcome has none for another, and that distinction is where peptide marketing lives.
1
Molecules with human evidence
For the use they are sold for, out of 1 products reviewed here. The evidence belongs to the molecule, not to Peak Wellness.
1
Registry records cited
Each read live from ClinicalTrials.gov, never from memory. None of them tested this company's product.
The comparison
What they claim, against what the trials show
Each claim below is quoted verbatim from Peak Wellness’s own page, with the page it came from. Grading a paraphrase would prove nothing. Every row is the verdict at a glance — tap it to open the quote, the trial registry entries, and the full note behind that verdict.
Compounded GLP-1 injectionTirzepatide · Compounded (503A)Claim reaches past the trials
“20-22% average body weight loss in clinical trials […] Peak Wellness partners with licensed physicians and regulated 503A compounding pharmacies. Every prescription is reviewed by a board-certified obesity medicine physician within 24 hours. […] FDA Disclaimer: Compounded medications are not FDA-approved. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S.”
Read on the Peak Wellness site, August 2026
Phase 3 trials
What the trials show for Tirzepatide
- NCT04184622 SURMOUNT-1 — Phase 3, completed, n=2,539. Tirzepatide over 72 weeks; roughly 20–22% mean reduction AT THE HIGHEST TOLERATED DOSE, with lifestyle intervention in every arm. Lower doses produced less.
The number is real and its placement is wrong, twice over. 20-22% is what tirzepatide achieved in SURMOUNT-1 at the highest tolerated dose — a top-of-range result for participants who reached and stayed on that dose, not an average across the trial. Describing it as an “average” moves a ceiling into the middle of the distribution, which is precisely the shift that makes a trial figure misleading. And it is a trial of the FDA-approved branded drug, not of a compounded preparation. Peak's own FDA disclaimer says compounded medications are not FDA-approved, so the site states the qualification it needs and then does not apply it to its headline.1
Dispensing chain
Who actually fills your prescription
- Emerald Compounding Pharmacy (EmeraldsRx) — 5325 Primrose Lake Circle, Suite A, Tampa, FL 33647, +1 (321) 321-3313, emeraldsrx.com
- Epiq Scripts — 465 W President George Bush Hwy, Richardson, TX 75080, 833-654-3553, epiqscripts.com
- Southend Pharmacy — 415 Westheimer Rd., Ste 103, Houston, TX 77006, 855-414-5356, southendpharmacystore.com
- AbsoluteRX (Absolute Pharmacy) — 16011 N. Nebraska Ave., Suite 103, Lutz, FL 33549, 844-338-2200, absoluterx.com
Read the full account
Re-checked 2026-08-26: Peak names four pharmacies, not one, and this review previously listed only Emerald. The FAQ answer to "Which pharmacies does Peak Wellness partner with?" gives each of them a phone number, an email address, a street address and a link to its own site — Emerald Compounding Pharmacy (EmeraldsRx) in Tampa, Epiq Scripts in Richardson, Southend Pharmacy in Houston and AbsoluteRX in Lutz. That is the most complete supply-chain disclosure in this batch by some distance, and every one of them can be looked up against a state board. It also names its provider group: "Peak Wellness partners with Dr. TelX (drtelx.com) for all medical consultations and prescriptions." It states the regulatory category as "regulated 503A compounding pharmacies" and says every prescription is reviewed by a board-certified obesity medicine physician within 24 hours. One phrase inside the signup is looser than the rest: a chart screen describes compounded GLP-1s as "produced in pharmacies regulated by the FDA and State Boards of Pharmacy", while the checkout screen gets it right — "compounding pharmacies are licensed and inspected by Boards of Pharmacy, but the FDA has not evaluated the medications".
Read on the Peak Wellness site, August 2026.
Quality
Third-party testing, and what is published
Describes a testing regime
Nothing published on the pages searched
Certificate of analysis readable
No lot report a buyer can open
Read the full testing account
No certificate of analysis or test result is published, despite the compounding pharmacy being named. That is the one gap the naming makes conspicuous rather than closes — a reader now knows exactly who to ask, and the site still does not provide it.
Read on the Peak Wellness site, August 2026.
Licensing
Licensed to dispense, and where
Coverage
Re-checked 2026-08-26: it does answer this, and this review previously said it did not. The FAQ reads "Peak Wellness serves patients in all 50 states. Our telehealth services and partner pharmacy network are available nationwide," and the state question inside the signup lists all fifty with none excluded.
Read the full licensing claim
regulated 503A compounding pharmacies, with all medical consultations and prescriptions through Dr. TelX (drtelx.com), and every prescription reviewed by a board-certified obesity medicine physician within 24 hours
Read on the Peak Wellness site, August 2026.
Regulatory
The FDA warning letter
Checked, and none found
We did this ourselves
What happens when you sign up with Peak Wellness
We went through Peak Wellness’s signup ourselves in August 2026 to find out what you actually meet before you pay — the steps, when a price appears, and what it asks for. We used placeholder answers, and we stopped before paying, so nothing here is a prescription or a medical outcome. It is what the screens showed.
- Pick a medication on the home page — both prices are already printed on the cards — and press Select.
- Say what your primary health goal is, from six options.
- An interstitial: "We've helped over 100,000+ members".
- Say the main reason you want to change, from four options.
- A second interstitial, this one making three health claims with no source attached.
- Pick your state from a searchable list of all fifty.
- Date of birth, then gender at birth.
- Enter an email address to create an account. No password is asked for, and two marketing-consent boxes sit under it.
- Height and weight, then your weight-loss goal from four ranges.
- A chart screen showing what members reported losing over five months, with the method and the compounded caveat printed under it.
- Bariatric surgery, then three medical checklists, then prior weight-loss treatment and current medications.
- A free-text box for anything else your provider should know.
- A recommendation screen names a medication, prices it against a struck-through figure and starts a 15-minute countdown. This walk stopped at the checkout button.
- Both molecules are priced on the home page before any question, and each has its own ladder behind a toggle. Semaglutide: $179 first month, $249/mo after, $199/mo billed every three months, $165/mo billed every six. Tirzepatide: $279 first month, $349/mo after, $279/mo on three months, $232/mo on six.
- The banner figure is the semaglutide first month. From month two the same plan is $249, and the tirzepatide equivalent is $349.
- The “Save $150 vs monthly” line on the three-month plan is measured against the standing rate rather than against what a new patient pays. A new semaglutide patient paying month to month spends $179 then two months at $249, so the three-month plan saves less than the badge says in year one.
- The homepage slider that offers to show "how much weight can you lose" returns a flat 15% of whatever weight you enter. We tried 140, 180, 250 and 320 lb and the answer was 15% every time.
- The recommendation screen prices semaglutide with a "16% average weight loss" line, while the homepage card for the same product says "15-20% average body weight loss".
- Your approval arrives on a 15-minute countdown at the checkout screen.
- The signup asks for an email but no password, so the account gate is lighter than most in this batch.
- Its FAQ names four pharmacies with addresses and phone numbers, and names Dr. TelX as the provider group behind every consultation.
Peak Wellness support
- support@trypeak.com
Assessment
What holds up, and what does not
- It names four compounding pharmacies with a street address, a phone number, an email and a link each — Emerald (EmeraldsRx), Epiq Scripts, Southend and AbsoluteRX — turning the supply chain from an assertion into something a reader can verify independently.
- It names its provider group too: Dr. TelX handles all consultations and prescriptions.
- The signup publishes a reported-outcome chart with the method attached — members' own reported weights, taken every three to four weeks, with the compounded caveat printed under it.
Show 4 more
- It states the regulatory category, 503A, rather than an unspecified “licensed pharmacy”.
- It carries an explicit FDA disclaimer that compounded medications are not FDA-approved, and attributes the Ozempic and Wegovy trademarks correctly.
- Every prescription is stated to be reviewed by a board-certified obesity medicine physician within 24 hours.
- The renewal rate is printed against the entry rate rather than discovered later.
- “20-22% average body weight loss in clinical trials” is a top-of-range result described as an average, which shifts a ceiling into the middle of the distribution.
- That result comes from a trial of FDA-approved branded tirzepatide, not of the compounded preparation Peak sells — a distinction its own disclaimer states and its headline ignores.
- No certificate of analysis is published even though the pharmacy is named, which is the one gap naming makes more conspicuous rather than less.
Show 6 more
- The advertised entry figure is the semaglutide first month. Tirzepatide starts higher, and both standing rates are higher again from month two.
- Its homepage calls semaglutide "15-20% average body weight loss" while the recommendation screen inside the signup calls the same product "16% average weight loss".
- An interstitial partway through the signup asserts that losing 12% of body fat "can boost your lifespan by 6.8 years" and that lower A1C "lessens metabolic syndrome by 14x", with no source for either.
- The checkout puts a 15-minute countdown on your approval.
- The lower effective price requires a six-month prepay.
- The site does not say what happens to the price as the dose is titrated upward.
Verdict
The bottom line
Peak is more checkable than almost anything else in this category because it names four pharmacies and its provider group in full — use that, and ask them for a certificate of analysis, which the site does not publish. Then price the month you will actually be buying: the advertised figure is a semaglutide first month, and both molecules cost more from month two. Discount the 20-22% as well; that is what branded tirzepatide did at its highest dose in a trial, not an average and not a measurement of what Peak sells.
Opens trypeak.com. A link is not a recommendation to take anything.
The thing it does that nobody else does
Peak Wellness names its compounding pharmacies — all four of them, re-checked on 26 August 2026, each with a street address, a phone number, an email and a link:
- Emerald Compounding Pharmacy (EmeraldsRx), Tampa, FL
- Epiq Scripts, Richardson, TX
- Southend Pharmacy, Houston, TX
- AbsoluteRX (Absolute Pharmacy), Lutz, FL
It names its provider group too: "Peak Wellness partners with Dr. TelX (drtelx.com) for all medical consultations and prescriptions."
That changes what a reader can do. "Our trusted pharmacy partners" — the standard phrasing across this category — is unfalsifiable. A named pharmacy can be looked up against its state board, checked for disciplinary history, and asked directly for a certificate of analysis covering your lot.
Peak also states the regulatory category (503A) and says every prescription is reviewed by a board-certified obesity medicine physician within 24 hours. Both are specific enough to be wrong, which is what makes them worth something.
Full analysis — 5 more sectionsWhat you will actually pay · The number the slider gives you · The claim that does not survive checking · What is still missing · What this means if you are buying
What you will actually pay
Every figure is public before you answer anything, which is to Peak's credit. What is easy to miss is that there are two ladders, one per molecule, behind a toggle — and that the banner quotes the cheapest rung of the cheaper one.
Semaglutide — $179 first month, then $249/mo. Or $199/mo billed every three months, or $165/mo billed every six.
Tirzepatide — $279 first month, then $349/mo. Or $279/mo billed every three months, or $232/mo billed every six.
So "Start For Just" is a semaglutide first month. From month two the monthly plan costs the standing rate, and the tirzepatide equivalents are higher again.
One arithmetic detail worth knowing: the three-month plan’s “Save $150 vs monthly” badge is measured against the standing rate times three. A new patient does not pay that — their first month is discounted — so in year one the real saving is smaller than the badge.
The number the slider gives you
The homepage carries a slider offering to show "how much weight can you lose". It is not a model of anything. Set it to 140 lb and it answers −21. Set it to 180 and it answers −27. Set it to 250 and it answers −38; 320 and it answers −48. Every one of those is 15% of the number you typed, returned as a personalized projection.
The claim that does not survive checking
"20-22% average body weight loss in clinical trials"
That range is real. It is what tirzepatide achieved in SURMOUNT-1, a phase 3 trial of 2,539 participants over 72 weeks. 1
Two things are wrong with how it is used.
It is not an average. 20-22% is the result at the highest tolerated dose, among participants who reached and stayed on it. An average across the trial — including lower doses and everyone who discontinued — is a smaller number. Calling a ceiling an average moves the whole distribution.
It is not a trial of this product. SURMOUNT-1 tested branded tirzepatide, an FDA-approved finished drug made to a registered specification. Peak sells a compounded preparation. Same molecule, different article, and the trial measured the article.
The sharpest detail: Peak's own FDA disclaimer says "Compounded medications are not FDA-approved." The site holds the qualification its headline needs, on the same site, and does not apply it.
What is still missing
No certificate of analysis. No potency result. No purity result.
That absence is more conspicuous here than elsewhere, precisely because the pharmacy is named. At a company that names nobody, there is no one to ask. Here there is — and the site still does not publish anything.
What this means if you are buying
Peak has given you the tool most of this category withholds. Use it: contact EmeraldsRx, ask for the certificate of analysis for your lot, and check the pharmacy against its state board.
Then set your expectations from the trial rather than the headline. 20-22% is what the approved drug did at its maximum dose in people who tolerated it.
Questions
Frequently asked questions
Is the 20-22% weight loss figure accurate?
The number is real; its description is not. It is what tirzepatide achieved at the highest tolerated dose in the SURMOUNT-1 phase 3 trial — a top-of-range result, not an average — and it comes from a trial of the FDA-approved branded drug rather than of the compounded preparation Peak sells.
Which pharmacy compounds Peak Wellness medication?
Emerald Compounding Pharmacy, trading as EmeraldsRx, named directly on the site. That is unusual and useful: a named pharmacy can be checked against its state board and asked for a certificate of analysis, neither of which is possible when a company names nobody.
Does Peak publish test results?
No. No certificate of analysis, potency result or purity result is published — which stands out more here than elsewhere, because the pharmacy is named and could be asked for one.
Compare
Others selling what Peak Wellness sells
Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.
Method
How we checked this
Non-product facts last checked August 2026. Read the editorial policy for the rules this page is held to.
Read our methodology
Claims read first-party
Every quoted claim was read off Peak Wellness's own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.
Trials read from the registry
Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.
Absence claims bounded
Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.
Letters matched on full name
FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.
Sources
References
Show all 1 sources
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine 387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.